Skip to content

Assessment of Rectus Abdominis Muscle Thickness and Residual Bladder Volume Before and After Pelvic Floor Exercises

Ultrasound Assessment of Rectus Abdominis Muscle Thickness and Residual Bladder Volume Before and After Pelvic Floor Exercises

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07004738
Acronym
Ultrasound
Enrollment
40
Registered
2025-06-04
Start date
2025-05-26
Completion date
2025-09-30
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Disorders

Keywords

pelvic floor exercises, rectus abdominis muscle thickness, residual bladder

Brief summary

The study will be conducted on 40 women between the ages of 20-40 who volunteer to participate in the study. All participants will be selected from individuals who have been diagnosed with pelvic floor dysfunction and have no history of pelvic surgery. Pelvic floor dysfunction will be diagnosed by an Obstetrics and Gynecology Specialist. Participants will be divided into two groups as the Pelvic floor exercise group and the control group.

Detailed description

The study will be conducted on 40 women between the ages of 20-40 who volunteer to participate in the study. All participants will be selected from individuals who have been diagnosed with pelvic floor dysfunction and have no history of pelvic surgery. Pelvic floor dysfunction will be diagnosed by an Obstetrics and Gynecology Specialist. Participants will be divided into two groups as the Pelvic floor exercise group and the control group. Group distributions will be made by randomization.org website. Participants in the pelvic floor exercise group will be instructed to do daily pelvic floor exercises under the guidance of a physiotherapist specialized in pelvic health. No exercises will be given to women diagnosed with pelvic floor dysfunction in this group. Women will continue their routine lives and their evaluations will be made.

Interventions

The bladder should be emptied before the exercise. In order to correctly identify the pelvic floor muscles, it is necessary to initially try to hold urine while emptying the bladder. If the result is successful, it means that the correct muscles have contracted. During the learning phase, the exercise can be done in a supine position with the legs bent at the knees or in a sitting position. Initially, the pelvic floor muscles should be contracted for 5 seconds by pulling them inward as if stopping the passage of urine or gas, and then rested for 5 seconds.

OTHERControl group

Women in this group who have been diagnosed with pelvic floor dysfunction will not be given any exercises. Women will continue their routine lives and their evaluations will be made.

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants will be masked.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* were being between 20-40 years of age, * having pelvic floor dysfunction, * not having any problems that would prevent performing pelvic floor exercises

Exclusion criteria

* previous pelvic surgery * active urinary tract infections * neurological conditions affecting bladder control

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound Measurements20 minutesUltrasound measurements will be performed at two points: at baseline (before the exercise program) and after 6 weeks of intervention. A high-resolution ultrasound device will be used to measure the thickness and cross-sectional area of the rectus abdominis muscle at rest.
The residual bladder volume measurement20 minutesThe residual bladder volume immediately after voiding will also be measured by ultrasonography to assess bladder control.A normal post-void residual volume is between 50 mL (milliliters) and 100 mL.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026